Seeking patient care?
Faculty in the Division of Hematology conduct basic, translational, and clinical research aimed at improving current and future standards of diagnosis and care for patients with blood disorders. Investigators explore mechanisms of disease and therapeutic resistance, play an active role in clinical trials, outcomes research, and regulatory science within the NCI-designated Sylvester Comprehensive Cancer Center.
Research within the division is supported by a robust portfolio of investigator-initiated studies, national cooperative group trials, and international collaborations. Division research has contributed to the development and approval of new therapies, advances in precision medicine, and novel targeted and immunotherapeutic approaches. Faculty regularly publish in leading peer-reviewed journals and participate in multidisciplinary programs across the cancer center under the leadership of Mikkael A. Sekeres, M.D., MS, Division Chief of Hematology.